Prototyping and Validating Novel Scalable Biomimetic Bioreactors for Low Carbon Cultivated Meat Production

用于低碳栽培肉生产的新型可扩展仿生生物反应器的原型设计和验证

基本信息

  • 批准号:
    10072878
  • 负责人:
  • 金额:
    $ 93.91万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Collaborative R&D
  • 财政年份:
    2023
  • 资助国家:
    英国
  • 起止时间:
    2023 至 无数据
  • 项目状态:
    未结题

项目摘要

Global food systems need to produce 50% more food to sustain growing populations over the next 40years, whilst substantially reducing greenhouse gas (GHG) emissions associated with food production and consumption (Social Market Foundation, 2020). According to the Independent Panel on Climate Change, 14% of total GHG emissions are attributable to the world's meat supply, without changes throughout the value chain, food systems emissions are likely to increase by 30-40% by 2050 (IPCC,2020).Research shows that within a decade Cultivated Meat will reduce 17% GHG for the creation of chicken, reduce by 52% to make pork and reduce by 92% to make beef. It will also reduce land use by 63% for chicken, 72% for pork and 95% for beef (Good Food Institute,2021). While production costs are currently between 100-10,000 times higher than for comparable animal meat products, with the right scale up technologies and prices could reach a competitive point earlier than 2030\. Progress in the industry has been slow but in the last decade cultivated meat has gone form the first lab grown burger costing \>$250,000 in 2013 to cultivated chicken being approved in the USA and sold in Singapore restaurants/markets in 2023\.Animal Alternative Technologies is an engineering B2B company based in the University of Cambridge. We are creating a scalable, end-to-end ecosystem for Cultivated Meat production, including specialist processes, enabling technologies, software, hardware and raw materials. Our mission is to democratise access to sustainable food and tackle some of the world's biggest sustainability and food security challenges. Our collaboration with the University of Manchester and University of Cambridge during this R&D project aims to develop a novel bioreactor technology that enables meat producers to create their own tailored, cultivated meat products for market at scale. We will do this by developing our novel scaffold and bioreactor system which enables cultivated meat producers to produce a plethora of affordable meat products (starting with lamb and pork), that are scalable, nutritious, delicious, for general consumption, with a lower environmental impact, higher quality meat, stronger local supply chains, and ethically sources.To date, we have raised over £3million from VCs and strategic investors, and have developed several patents/pioneering technologies, including hydrogels, cell lines, and bioelectronic sensors. Our work has received multiple awards, and AAT has participated in 4 accelerators. We have received coverage from TechCrunch, Food Navigator, The Spoon, etc., and are driven to tackle food security and sustainability challenges.
全球粮食系统需要生产50%以上的粮食,以维持未来40年不断增长的人口,同时大幅减少与粮食生产和消费相关的温室气体(GHG)排放(社会市场基金会,2020年)。根据气候变化独立小组的数据,温室气体排放总量的14%可归因于世界肉类供应,如果整个价值链不发生变化,到2050年,食品系统的排放量可能会增加30-40%。(IPCC,2020年)。研究表明,在十年内,种植肉类将减少17%的温室气体用于生产鸡肉,减少了52%,使猪肉和减少了92%,使牛肉。它还将减少鸡肉63%,猪肉72%和牛肉95%的土地使用(Good Food Institute,2021)。虽然目前的生产成本比同类动物肉类产品高出100- 10,000倍,但如果技术和价格能够适当扩大,那么在2030年之前就可以达到竞争力。该行业的进展一直很缓慢,但在过去的十年中,人工培育的肉类已经从2013年第一个实验室培育的汉堡花费25万美元,到2023年在美国获得批准并在新加坡餐馆/市场销售的人工培育的鸡肉。我们正在为养殖肉类生产创建一个可扩展的端到端生态系统,包括专业流程,支持技术,软件,硬件和原材料。我们的使命是使可持续粮食的获取民主化,并应对世界上一些最大的可持续性和粮食安全挑战。我们与曼彻斯特大学和剑桥大学在这个研发项目中的合作旨在开发一种新型的生物反应器技术,使肉类生产商能够为市场大规模生产他们自己定制的养殖肉类产品。我们将通过开发新的支架和生物反应器系统来实现这一目标,使养殖肉类生产商能够生产大量负担得起的肉类产品。(从羊肉和猪肉开始),可扩展,营养,美味,一般消费,环境影响较低,肉类质量更高,本地供应链更强大,来源符合道德。迄今为止,我们已经从风险投资者和战略投资者那里筹集了超过300万英镑,并开发了多项专利/开创性技术,包括水凝胶、细胞系和生物电子传感器。我们的工作获得了多个奖项,AAT参加了4个加速器。我们已经收到了来自TechCrunch,Food Navigator,The Spoon等的报道,并致力于应对粮食安全和可持续性挑战。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

其他文献

吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
生命分子工学・海洋生命工学研究室
生物分子工程/海洋生物技术实验室
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:

的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('', 18)}}的其他基金

An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
  • 批准号:
    2901954
  • 财政年份:
    2028
  • 资助金额:
    $ 93.91万
  • 项目类别:
    Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
  • 批准号:
    2896097
  • 财政年份:
    2027
  • 资助金额:
    $ 93.91万
  • 项目类别:
    Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
  • 批准号:
    2780268
  • 财政年份:
    2027
  • 资助金额:
    $ 93.91万
  • 项目类别:
    Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
  • 批准号:
    2908918
  • 财政年份:
    2027
  • 资助金额:
    $ 93.91万
  • 项目类别:
    Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
  • 批准号:
    2908693
  • 财政年份:
    2027
  • 资助金额:
    $ 93.91万
  • 项目类别:
    Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
  • 批准号:
    2908917
  • 财政年份:
    2027
  • 资助金额:
    $ 93.91万
  • 项目类别:
    Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
  • 批准号:
    2879438
  • 财政年份:
    2027
  • 资助金额:
    $ 93.91万
  • 项目类别:
    Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
  • 批准号:
    2890513
  • 财政年份:
    2027
  • 资助金额:
    $ 93.91万
  • 项目类别:
    Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
  • 批准号:
    2879865
  • 财政年份:
    2027
  • 资助金额:
    $ 93.91万
  • 项目类别:
    Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
  • 批准号:
    2876993
  • 财政年份:
    2027
  • 资助金额:
    $ 93.91万
  • 项目类别:
    Studentship

相似海外基金

Validating the performance and inclusivity of a novel functionally-informed predictive genetic test method for polygenic disease
验证多基因疾病的新型功能信息预测基因测试方法的性能和包容性
  • 批准号:
    10759476
  • 财政年份:
    2023
  • 资助金额:
    $ 93.91万
  • 项目类别:
Harvesting Actionable Results for Learning and Instruction: A Novel Mixed Methods Approach to Extracting and Validating Information from Diagnostic Assessment
收获可操作的学习和教学结果:一种从诊断评估中提取和验证信息的新型混合方法
  • 批准号:
    2300382
  • 财政年份:
    2023
  • 资助金额:
    $ 93.91万
  • 项目类别:
    Standard Grant
Validating novel candidate genes for normal-tension glaucoma
验证正常眼压性青光眼的新候选基因
  • 批准号:
    10749126
  • 财政年份:
    2023
  • 资助金额:
    $ 93.91万
  • 项目类别:
Validating novel DNA repair deficient cancer therapy targets and small molecule compounds
验证新型 DNA 修复缺陷癌症治疗靶点和小分子化合物
  • 批准号:
    10546636
  • 财政年份:
    2022
  • 资助金额:
    $ 93.91万
  • 项目类别:
Validating and refining novel predation tracking technology for wild fishes
验证和完善野生鱼类的新型捕食跟踪技术
  • 批准号:
    572230-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 93.91万
  • 项目类别:
    Alliance Grants
Developing and Validating a Novel Tau Toxicity Model in the Budding Yeast
开发并验证芽殖酵母中的新型 Tau 毒性模型
  • 批准号:
    10574327
  • 财政年份:
    2022
  • 资助金额:
    $ 93.91万
  • 项目类别:
Validating a novel microfluidic platform as an ex vivo tumour model for sarcoma drug discovery
验证新型微流体平台作为肉瘤药物发现的离体肿瘤模型
  • 批准号:
    486298
  • 财政年份:
    2022
  • 资助金额:
    $ 93.91万
  • 项目类别:
    Studentship Programs
Validating novel synthetically lethal vulnerabilities in lung cancer
验证肺癌中新的综合致命弱点
  • 批准号:
    2619070
  • 财政年份:
    2021
  • 资助金额:
    $ 93.91万
  • 项目类别:
    Studentship
Validating a Humanized Mouse HIV Model for Cognitive Deficits and Novel Treatments
验证人源化小鼠 HIV 模型的认知缺陷和新疗法
  • 批准号:
    10513293
  • 财政年份:
    2021
  • 资助金额:
    $ 93.91万
  • 项目类别:
Validating novel sleep sensors and devices in older adults with Alzheimer's disease
在患有阿尔茨海默病的老年人中验证新型睡眠传感器和设备
  • 批准号:
    10756674
  • 财政年份:
    2021
  • 资助金额:
    $ 93.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了